HIV-infected patients and liver transplantation: Who, when and why

Current HIV Research

Volumn 9, Issue 2, 2011, Pages 120-127

  Tavio, Marcello ^a   Grossi, Paolo ^b   Baccarani, Umberto ^c   Scudeller, Luigia ^d   Pea, Federico ^c   Berretta, Massimiliano ^e   Adani, Gianluigi ^c   Vivarelli, Marco ^f   Riva, Alessandra ^a   Tirelli, Umberto ^e   Bresadola, Vittorio ^c   Viale, Pierluigi ^g   Risaliti, Andrea ^f  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY HOSPITAL OF UDINE   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^f Azienda Ospedaliero Universitaria di Ancona   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

HBV; HCV; HIV; Liver transplantation; Selection criteria; Survival benefit

Indexed keywords

ANTIRETROVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; DRUG HYPERSENSITIVITY; END STAGE LIVER DISEASE; GRAFT SURVIVAL; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LIVER TOXICITY; LIVER TRANSPLANTATION; MIXED INFECTION; PANDEMIC; VIRUS LOAD;

EID: 79953310741     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016211795569159     Document Type: Article

References (55)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-8560.
2. Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 1998; 280: 1497-1503.
3. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human munodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30(1): S5-14.
4. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44: S6-9.
5. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. N Engl J Med 2007; 356: 1445-1454.
6. Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatol 2005; 41: 779-789.
7. Puoti M, Spinetti A, Ghezzi A, et al. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr 2000; 24: 211-217.
8. Soriano V, Garcia-Samaniego J, Rodriguez-Rosado R, et al. Hepatitis C and HIV infection: biological, clinical, and therapeutic implications. J Hepatol 1999; 31(1): 119-123.
9. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32: 492-497.
10. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Int Med 2006; 166: 1632-1641.
11. Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002; 347: 284-287.
12. Kuo PC, Stock PG. Transplantation in the HIV+ patient. Am J Transplant 2001; 1: 13-17.
13. Fishman JA. Transplantation for patients infected with human immunodeficiency virus: no longer experimental but not yet routine. J Infect Dis 2003; 188: 1405-1411.
14. Fauci AS, Pantaleo G, Stanley S, Weissman.Immunopathogenic Mechanisms of HIV Infection. Ann Intern Med 1996; 124: 654-663.
15. Shaffer D, Pearl RH, Jenkins RL, et al. HTLV-III/LAV infection in kidney and liver transplantation. Transplant Proc 1987; 19: 2176-2178.
16. Bouscarat F, Samuel D, Simon F, et al. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis 1994; 19: 854-859.
17. Tzakis AG, Cooper MH, Dummer JS, et al. Transplantation in HIV+ patients. Transplantation 1990; 49: 354-358.
18. Erice A, Rhame FS, Heussner RC, et al. Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis 1991; 13: 537-547.
19. Dummer JS, Erb S, Breinig MK, et al. Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation 1989; 47: 134-140.
20. Gordon FH, Mistry PK, Sabin CA, Lee CA Outcome of orthotopic liver transplantation in patients with haemophilia. Gut 1998; 42: 744-749.
21. Ward JW, Schable C, Dickinson GM, et al. Acute human immunodeficiency virus infection. Antigen detection and seroconversion in immunosuppressed patients. Transplantation 1989; 47: 722-724.
22. Vanhems P, Bresson-Hadni S, Vuitton DA, et al. Long-term survival without immunosuppression in HIV-positive livergraft recipient. Lancet 1991; 337: 126.
23. Jacobson SK, Calne RY, Wreghitt TG: Outcome of HIV infection in transplant patient on cyclosporin. Lancet 1991; 337: 794.
24. McCarthy M, Gane E, Pereira S, et al. Liver transplantation for haemophiliacs with hepatitis C cirrhosis. Gut 1996; 39: 870-875.
25. Ragni MV, Bontempo FA, Lewis JH. Organ transplantation in HIV-positive patients with hemophilia. N Engl J Med 1990; 322: 1886-1887.
26. Ockenga J, Tillmann HL, Trautwein C, et al. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 1997; 27: 18-24.
27. Schoenfeld P, Rodriguez R, Mendelson M: Patients with HIV infection and end-stage renal disease. Adv Ren Replace Ther 1996; 3: 287-92.
28. Ragni MV, Dodson SF, Hunt SC, et al. Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. Blood 1999; 93: 1113-1114.
29. Gow PJ, Mutimer D. Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy. AIDS 2001; 15: 291-292.
30. Prachalias AA, Pozniak A, Taylor C, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72: 1684-1688.
31. Tolan DJ, Davies MH, Millson CE: Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection. N Engl J Med 2001; 345: 1781.
32. Roland ME, Stock PG: Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003; 75: 425-429.
33. Rafecas A, Rufi G, Fabregat J, Xiol X. Liver transplantation in a patient infected by human immunodeficiency virus [in Spanish]. Med Clin (Barc) 2002; 119: 596.
34. Stock PG, Roland ME, Carlson L, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 2003; 76: 370-375.
35. Nowak P, Schvarcz R, Ericzon BG, et al. Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection. AIDS Res Hum Retroviruses 2003; 19: 13-19.
36. Jeng LB, Lee WC, Hung CM, et al. Liver transplantation in a patient with human immunodeficiency virus infection: a case report. Transplant Proc 2003; 35: 361.
37. Neff GW, Bonham A, Tzakis AG, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003; 9: 239-247.
38. Gonzalez AR, Barcena R, Blesa C, et al. Liver transplantation in a patient coinfected with human immunodeficiency virus and hepatitis C virus. Transplant Proc 2003; 35: 1846-1847.
39. Antoniades C, Macdonald C, Knisely A, et al. Mitochondrial toxicity associated with HAART following liver transplantation in an HIV-infected recipient. Liver Transpl 2004; 10: 699-702.
40. Norris S, Taylor C, Muiesan P, et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl 2004; 10: 1271-1278.
41. Rafecas A, Rufi G, Figueras J, et al. Liver transplantation without steroid induction in HIV-infected patients. Liver Transpl 2004; 10: 1320-1303.
42. Moreno S, Fortun J, Quereda C, et al. Liver transplantation in HIV-infected recipients. Liver Transpl 2005; 11: 76-81.
43. Radecke K, Fruhauf NR, Miller M, et al. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis. Liver Int 2005; 25: 101-108.
44. de Vera ME, Dvorchik I, Tom K, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant 2006; 6: 2983-2993.
45. Grossi P. Liver Transplantation in HIV-Positive Individuals: A New Paradigm. Transplant Proc 2006; 35: 1005-1006.
46. Mirò JM, Laguno M, Moreno A, Rimola A. Management of end stage liver disease (ESLD): what is the current role of ortotopic liver transplantation (OLT)? J Hepatol 2006; 44: S140-145.
47. Samuel D, Weber R, Stock P, Duclos Valle JC, Terrault N. Are HIV-infected patients candidates for liver transplantation? J Hepatol 2008; 48: 697-707.
48. Murillas J, Rimola A, Laguno M, et al. The Model for End-Stage Liver Disease Score Is the Best Prognostic Factor in Human Immunodeficiency Virus 1-Infected Patients with End-Stage Liver Disease: A Prospective Cohort Study. Liver Transpl 2009; 15: 1133-1141.
49. Subramanian A, Sulkowski M, Barin B, et al. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterol 2010; 138(1):159-164.
50. Ragni M, Eghtesad B, Schlesinger K, et al. Pre-transplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl 2005; 11: 1425-1430.
51. Stock P. Rapid deterioration of HIV coinfected patients waiting for liver transplantation is not predicted by MELD. Liver Transpl 2005; 11: 1315-1317.
52. Duclos-Vallee JC, Feray C, Sebagh M, et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatol 2008; 47: 407-417.
53. Adam R, Lucidi V, Karam V: Liver transplantation in Europe: is there a room for improvement? J Hepatol 2005; 42(1): 33-40.
54. Mindikoglu A, Regev A, Magder LS: Impact of Human Immunodeficiency Virus on Survival After Liver Transplantation: Analysis of United Network for Organ Sharing Database. Transplantation 2008; 85: 359-368.
55. Roland ME, Barinb B, Carlson L, et al. HIV-Infected Liver and Kidney Transplant Recipients: 1- and 3-Year Outcomes. Am J Transplant 2008; 8: 355-365.